Toyota Mobility Tokyo Inc., a sales arm of Toyota Motor Corp., admitted falsifying vehicle inspection results for 565 cars to complete the process within the allotted time.
The falsifications occurred at the Lexus Takanawa outlet of Toyota Mobility Tokyo, which set a limit of two hours to complete the vehicle inspection to allow customers to wait at the outlet for completion of the task.
Priority was placed on meeting that time limit.
Yasuhiko Sato, the Toyota Motor executive in charge of domestic sales, said the falsification was a result of prioritizing the completion of the legally prescribed vehicle inspections as quickly as possible.
The outlet handled 1,864 vehicle inspections after June 2019, with four inspectors found falsifying results for 565 vehicles.
Some of the falsifications were violative of the Road Transport Vehicles Law, such as for braking functions.
Some inspection items were omitted, such as speedometer accuracy and exhaust composition, while the results of other items, including braking function and headlight brightness, were falsified.
In March, a Toyota car dealership in Aichi Prefecture, where Toyota Motor is headquartered, was caught falsifying inspection results for 5,158 cars.


DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Asian Markets Surge as Japan Election, Fed Rate Cut Bets, and Tech Rally Lift Global Sentiment
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



